Zelanna Goldberg's most recent trade in Alpine Immune Sciences Inc was a trade of 160,000 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 1, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alpine Immune Sciences Inc | Zelanna Goldberg | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 160,000 | 160,000 | - | - | Stock Option (Right to buy) |